Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism | Vaiman | Personalized Psychiatry and Neurology

Personalized Psychiatry and Neurology

ISSN 2712-9179 (Online)

Preview

Personalized Psychiatry and Neurology

Advanced search

Archives

Download this PDF file

For citations:

Vaiman E.E., Novitsky M.A., Nasyrova R.F. Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism. Personalized Psychiatry and Neurology. 2021;1(1):11-17. https://doi.org/10.52667/2712-9179-2021-1-1-11-17

Views PDF (Eng): 782

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2712-9179 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Nikolay G. Neznanov

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

E. E. Vaiman
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation

Elena E. Vaiman

192019, St.Petersburg, Russian Federation; tel.: +79644331333

M. A. Novitsky
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation

Maxim A. Novitsky

192019, St.Petersburg, Russian Federation

R. F. Nasyrova
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation

Regina F. Nasyrova

192019, St.Petersburg, Russian Federation; tel.: +7(812)6700220 7813

Notifications